Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 16.48 USD -1.79% Market Closed
Market Cap: 545.2m USD

Wall Street
Price Targets

NPCE Price Targets Summary
Neuropace Inc

Wall Street analysts forecast NPCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NPCE is 17.85 USD with a low forecast of 15.15 USD and a high forecast of 21 USD.

Lowest
Price Target
15.15 USD
8% Downside
Average
Price Target
17.85 USD
8% Upside
Highest
Price Target
21 USD
27% Upside
Neuropace Inc Competitors:
Price Targets
STMN
Straumann Holding AG
19% Upside
NVST
Envista Holdings Corp
2% Upside
NXTMH
Nexstim Oyj
10% Downside
9996
Peijia Medical Ltd
70% Upside
NYXH
Nyxoah SA
131% Upside
GMED
Globus Medical Inc
6% Upside
ELN
El En SpA
1% Upside
CVRX
CVRx Inc
39% Upside

Revenue
Forecast

Revenue Estimate
Neuropace Inc

For the last 4 years the compound annual growth rate for Neuropace Inc's revenue is 18%. The projected CAGR for the next 3 years is 17%.

18%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Neuropace Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Neuropace Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NPCE's stock price target?
Price Target
17.85 USD

According to Wall Street analysts, the average 1-year price target for NPCE is 17.85 USD with a low forecast of 15.15 USD and a high forecast of 21 USD.

What is Neuropace Inc's Revenue forecast?
Projected CAGR
17%

For the last 4 years the compound annual growth rate for Neuropace Inc's revenue is 18%. The projected CAGR for the next 3 years is 17%.

Back to Top